An annual report filed last week by Medbox, a medical marijuana dispensary caught up in a range of litigation and regulatory issues, shows that it gave two outside law firms stakes worth a total of almost $280,000 about two months before it was sold to private equity firm Lizada Capital.
Medbox, in its most recent 10-K filing with the U.S. Securities and Exchange Commission, states that between Oct. 1, 2014, and Dec. 31, 2014, it issued 46,352 shares to Manatt, Phelps & Phillips at $5.11 per share and another 6,540 shares to securities boutique Sichenzia Ross Friedman Ference at a price of $6.59 per share. The issuance of shares puts the value of Sichenzia Ross’ stake in Medbox at $43,098.60 and Manatt’s holdings at $236,858.72.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
